Search results
The Supreme Court reversed the decision of the court of appeal affirming the finding of the City of San Diego that adoption of an ordinance authorizing the establishment of medical marijuana dispensaries and regulating their location and operation did not constitute a project, holding that the court of appeal misapplied the test for determining ...
In the rapidly evolving legal landscape of employment law, California stands on the brink of implementing pivotal cannabis-related legislation. These new laws, slated to take effect on January 1, 2024, are set to bring substantial changes to workplace policies and employee rights across the state.
Guidelines for the Security and Non-Diversion of Cannabis Grown for Medical Use. In 1996, California voters approved Proposition 215, the Compassionate Use Act of 1996, which exempted certain patients and their primary caregivers from criminal liability under state law for the possession and cultivation of marijuana for medicinal use.
Medicinal Cannabis Guidelines. In 1996, California voters approved Proposition 215, the Compassionate Use Act of 1996, which exempted certain patients and their primary caregivers from criminal liability under state law for the possession and cultivation of marijuana for medicinal use.
California became the first U.S. state to legalize the medical use of marijuana.3 Proposition 215 passed in 1996, and the Compassionate Use Act was born. The Proposition contained somewhat vague wording, which has been clarified by subsequent laws and court decisions. In 2003, California Governor Gray Davis signed the Medical Marijuana
While overshadowed by the criminal and administrative law effects, medical marijuana raises important issues concerning doctors’ and patients’ rights, specifically medical autonomy, as well as medical malpractice issues such as overuse by patients, over-prescription by doctors for monetary gain, and use by non-patients, including second ...
Treatment Agreement: Treatment plans with objectives should be established with the patient as early as possible in the treatment process and revisited regularly, so as to provide clear-cut, individualized objectives to guide the choice of therapies, both pharmacologic and non-pharmacologic.
